Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer

Nature Genetics

Volumn 39, Issue 2, 2007, Pages 162-164

  Reid, Sarah ^a   Schindler, Detlev ^b   Hanenberg, Helmut ^c,d   Barker, Karen ^a   Hanks, Sandra ^a   Kalb, Reinhard ^b   Neveling, Kornelia ^b   Kelly, Patrick ^a   Seal, Sheila ^a   Freund, Marcel ^c   Wurm, Melanie ^c   Batish, Sat Dev ^e,f   Lach, Francis P ^e   Yetgin, Sevgi ^g   Neitzel, Heidemarie ^h   Ariffin, Hany ⁱ   Tischkowitz, Marc ^j,k   Mathew, Christopher G ^l   Auerbach, Arleen D ^e   Rahman, Nazneen ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ROCKEFELLER UNIVERSITY   (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

^g HACETTEPE UNIVERSITY   (Turkey)

^h CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

ⁱ UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^j MCGILL UNIVERSITY   (Canada)

^k MCGILL UNIVERSITY   (Canada)

^l GUY S HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; NUCLEAR FACTOR; PARTNER AND LOCALIZER OF BRCA2 PROTEIN; PROTEIN FANCN; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHILDHOOD CANCER; FANCONI ANEMIA; GENE MUTATION; HUMAN; PRIORITY JOURNAL;

ALLELES; BREAST NEOPLASMS; CHILD, PRESCHOOL; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; MUTATION; NUCLEAR PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 33846569450     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng1947     Document Type: Article

References (15)

1. Kutler, D.I. et al. Blood 101, 1249-1256 (2003).
2. Niedernhofer, L.J., Lalai, A.S. & Hoeijmakers, J.H.J. Cell 123, 1191-1198 (2005).
3. Taniguchi, T. & D'Andrea, A.D. Blood 107, 4223-4233 (2006).
4. Shivji, M.K. & Venkitaraman, A.R. DNA Repair (Amst.) 3, 835-843 (2004).
5. The Breast Cancer Linkage Consortium. J. Natl. Cancer Inst. 91, 1310-1316 (1999).
6. Howlett, N.G. et al. Science 297, 606-609 (2002).
7. Offit, K. et al. J. Natl. Cancer Inst. 95, 1548-1551 (2003).
8. Hirsch, B. et al. Blood 103, 2554-2559 (2004).
9. Wagner, J.E. et al. Blood 103, 3226-3229 (2004).
10. Reid, S. et al. J. Med. Genet. 42, 147-151 (2005).
11. Xia, B. et al. Mol. Cell 22, 719-729 (2006).
12. Lejeune, F. & Maquat, L.E. Curr. Opin. Cell Biol. 17, 309-315 (2005).
13. Godthelp, B.C. et al. Mutat. Res. 594, 39-48 (2006).
14. de Chadarevian, J.P., Vekemans, M. & Bernstein, M. Arch. Pathol. Lab. Med. 109, 367-369 (1985).
15. Chandra, S. et al. Mol. Ther. 12, 976-984 (2005).